Molecular imprinting is a very powerful tool in life science. The research areas benefiting from a wide range of capabilities of molecularly imprinted polymeric nanoparticles (nanoMIPs) include sample preparation, extraction, sensing/detection, diagnostics, and drug delivery. Recently, a new member of this family-therapy/control of cellular reactions-has arrived. Within this newest field, so far, the design and synthesis of very selective enzymatic inhibitors/activators have been described. Since enzymes act as catalysts of biochemical reactions, nanoMIPs pose enormous potential in managing biological processes. Furthermore, in recent years, articles focused on influencing cellular pathways by either interaction with cell surface receptors or by inactivation of signal molecules have begun to appear. This strategy opens a new perspective for nanoMIPs application-as selective, inexpensive, and stable therapeutics. However, there are still a lot of questions to be answered and many issues that must be addressed before the practical implementation of nanoMIPs in the therapeutic area. Among the main challenges belong safety, biodegradability, biodistribution, and clearance of nanoMIPs from the organism as well as their reproducible large-scale production in accordance with quality control. This review aims to summarize the progress in nanoMIPs development enabling them to overcome main issues and increasing their competitiveness in the therapeutic area.

Department of Chemistry and Biochemistry Mendel University in Brno Brno Czech Republic

Zobrazit více v PubMed

Friedman D. I., Olson E. R., Georgopoulos C., Tilly K., Herskowitz I., and Banuett F., “Interactions of Bacteriophage and Host Macromolecules in the Growth of Bacteriophage Lambda,” Microbiological Reviews 48, no. 4 (1984): 299–325. PubMed PMC

Lu R.‐M., Hwang Y.‐C., Liu I. J., et al., “Development of Therapeutic Antibodies for the Treatment of Diseases,” Journal of Biomedical Science 27, no. 1 (2020): 1. PubMed PMC

Bártíková H., Podlipná R., and Skálová L., “Veterinary Drugs in the Environment and Their Toxicity to Plants,” Chemosphere 144 (2016): 2290–2301. PubMed

Chen Z., Wang X., Chen X., et al., “Accelerating Therapeutic Protein Design With Computational Approaches Toward the Clinical Stage,” Computational and Structural Biotechnology Journal 21 (2023): 2909–2926. PubMed PMC

Mitchell M. J., Billingsley M. M., Haley R. M., Wechsler M. E., Peppas N. A., and Langer R., “Engineering Precision Nanoparticles for Drug Delivery,” Nature Reviews Drug Discovery 20, no. 2 (2021): 101–124. PubMed PMC

Wang B., Xie K., and Lee K., “Veterinary Drug Residues in Animal‐Derived Foods: Sample Preparation and Analytical Methods,” Foods 10, no. 3 (2021): 555. PubMed PMC

Bărăian A.‐I., Iacob B.‐C., Bodoki A. E., and Bodoki E., “In Vivo Applications of Molecularly Imprinted Polymers for Drug Delivery: A Pharmaceutical,” Perspective 23, no. 22 (2022): 14071. PubMed PMC

Yarman A., Jetzschmann K. J., Neumann B., et al., “Enzymes as Tools in MIP‐Sensors,” Chemosensors 5, no. 2 (2017): 11.

Suzaei F. M., Daryanavard S. M., Abdel‐Rehim A., Bassyouni F., and Abdel‐Rehim M., “Recent Molecularly Imprinted Polymers Applications in Bioanalysis,” Chemical Papers 77, no. 2 (2023): 619–655. PubMed PMC

Kang M. S., Cho E., Choi H. E., Amri C., Lee J.‐H., and Kim K. S., “Molecularly Imprinted Polymers (MIPs): Emerging Biomaterials for Cancer Theragnostic Applications,” Biomaterials Research 27, no. 1 (2023): 45. PubMed PMC

Pan J., Chen W., Ma Y., and Pan G., “Molecularly Imprinted Polymers as Receptor Mimics for Selective Cell Recognition,” Chemical Society Reviews 47, no. 15 (2018): 5574–5587. PubMed

El‐Schich Z., Zhang Y., Feith M., et al., “Molecularly Imprinted Polymers in Biological Applications,” Biotechniques 69, no. 6 (2020): 407–420. PubMed

Bodoki A. E., Iacob B.‐C., and Bodoki E., “Perspectives of Molecularly Imprinted Polymer‐Based Drug Delivery Systems in Cancer Therapy,” Polymers 11, no. 12 (2019): 2085. PubMed PMC

Louadj L., Pagani A., Benghouzi P., Sabbah M., and Griffete N., “How Molecularly Imprinted Polymers Can Be Used for Diagnostic and Treatment of Tropical Diseases?,” Chemistry Africa 6, no. 1 (2023): 3–14, 10.1007/s42250-022-00397-2. DOI

Haupt K., Medina Rangel P. X., and Bui B. T. S., “Molecularly Imprinted Polymers: Antibody Mimics for Bioimaging and Therapy,” Chemical Reviews 120, no. 17 (2020): 9554–9582. PubMed

Piletsky S., Canfarotta F., Poma A., Bossi A. M., and Piletsky S., “Molecularly Imprinted Polymers for Cell Recognition,” Trends in Biotechnology 38, no. 4 (2020): 368–387. PubMed

Xu S., Wang L., and Liu Z., “Molecularly Imprinted Polymer Nanoparticles: An Emerging Versatile Platform for Cancer Therapy,” Angewandte Chemie International Edition 60, no. 8 (2021): 3858–3869. PubMed PMC

Ali M. M., Zhu S., Amin F. R., Hussain D., Du Z., and Hu L., “Molecular Imprinting of Glycoproteins: From Preparation to Cancer Theranostics,” Theranostics 12, no. 5 (2022): 2406–2426. PubMed PMC

Poma A., Guerreiro A., Whitcombe M. J., Piletska E. V., Turner A. P. F., and Piletsky S. A., “Solid‐Phase Synthesis of Molecularly Imprinted Polymer Nanoparticles With a Reusable Template—ʻPlastic Antibodiesʼ,” Advanced Functional Materials 23, no. 22 (2013): 2821–2827. PubMed PMC

Cáceres C., Moczko E., Basozabal I., Guerreiro A., and Piletsky S., “Molecularly Imprinted Nanoparticles (NanoMIPs) Selective for Proteins: Optimization of a Protocol for Solid‐Phase Synthesis Using Automatic Chemical Reactor,” Polymers 13, no. 3 (2021): 314. PubMed PMC

Gui R. and Jin H., “Recent Advances in Synthetic Methods and Applications of Photo‐Luminescent Molecularly Imprinted Polymers,” Journal of Photochemistry and Photobiology, C: Photochemistry Reviews 41 (2019): 100315.

Whitcombe M. J., Chianella I., Larcombe L., et al., “The Rational Development of Molecularly Imprinted Polymer‐Based Sensors for Protein Detection,” Chemical Society Reviews 40, no. 3 (2011): 1547–1571. PubMed

Ertürk G. and Mattiasson B., “Molecular Imprinting Techniques Used for the Preparation of Biosensors,” Sensors 17, no. 2 (2017): 288. PubMed PMC

Jahanban‐Esfahlan A., Roufegarinejad L., Jahanban‐Esfahlan R., Tabibiazar M., and Amarowicz R., “Latest Developments in the Detection and Separation of Bovine Serum Albumin Using Molecularly Imprinted Polymers,” Talanta 207 (2020): 120317. PubMed

Xu K., Wang Y., Wei X., Chen J., Xu P., and Zhou Y., “Preparation of Magnetic Molecularly Imprinted Polymers Based on a Deep Eutectic Solvent as the Functional Monomer for Specific Recognition of Lysozyme,” Microchimica Acta 185 (2018): 146. PubMed

Tamahkar E., Bereli N., Say R., and Denizli A., “Molecularly Imprinted Supermacroporous Cryogels for Cytochrome C Recognition,” Journal of Separation Science 34, no. 23 (2011): 3433–3440. PubMed

Kan X., Zhao Q., Shao D., Geng Z., Wang Z., and Zhu J.‐J., “Preparation and Recognition Properties of Bovine Hemoglobin Magnetic Molecularly Imprinted Polymers,” Journal of Physical Chemistry B 114, no. 11 (2010): 3999–4004. PubMed

Rachkov A. and Minoura N., “Recognition of Oxytocin and Oxytocin‐Related Peptides in Aqueous Media Using a Molecularly Imprinted Polymer Synthesized by the Epitope Approach,” Journal of Chromatography A 889, no. 1–2 (2000): 111–118. PubMed

Tse Sum Bui B., Mier A., and Haupt K., “Molecularly Imprinted Polymers as Synthetic Antibodies for Protein Recognition: The Next Generation,” Small 19, no. 13 (2023): 2206453. PubMed

Refaat D., Aggour M. G., Farghali A. A., et al., “Strategies for Molecular Imprinting and the Evolution of MIP Nanoparticles as Plastic Antibodies—Synthesis and Applications,” International Journal of Molecular Sciences 20, no. 24 (2019): 6304. PubMed PMC

https://www.sigmaaldrich.com/CZ/en/technical-documents/technical-article/analytical-chemistry/solid-phase-extraction/supelmip.

https://www.allergyamulet.com/.

https://www.freshairsensor.com/.

https://mipdiscovery.com/.

Vaneckova T., Bezdekova J., Han G., Adam V., and Vaculovicova M., “Application of Molecularly Imprinted Polymers as Artificial Receptors for Imaging,” Acta Biomaterialia 101 (2020): 444–458. PubMed

Włoch M. and Datta J., “Synthesis and Polymerisation Techniques of Molecularly Imprinted Polymers.” Comprehensive Analytical Chemistry (Elsevier, 2019), vol. 86, 17–40.

Yan H. and Row K. H., “Characteristic and Synthetic Approach of Molecularly Imprinted Polymer,” International Journal of Molecular Sciences 7, no. 5 (2006): 155–178.

Chen L., Xu S., and Li J., “Recent Advances in Molecular Imprinting Technology: Current Status, Challenges and Highlighted Applications,” Chemical Society Reviews 40, no. 5 (2011): 2922–2942. PubMed

Chianella I., Guerreiro A., Moczko E., et al., “Direct Replacement of Antibodies With Molecularly Imprinted Polymer (MIP) Nanoparticles in ELISA‐Development of a Novel Assay for Vancomycin,” Analytical Chemistry 85, no. 17 (2013). PubMed PMC

Poma A., Guerreiro A., Caygill S., Moczko E., and Piletsky S., “Automatic Reactor for Solid‐Phase Synthesis of Molecularly Imprinted Polymeric Nanoparticles (MIP NPs) in Water,” RSC Advances 4, no. 8 (2014): 4203–4206. PubMed PMC

Smolinska‐Kempisty K., Guerreiro A., Canfarotta F., Cáceres C., Whitcombe M. J., and Piletsky S., “A Comparison of the Performance of Molecularly Imprinted Polymer Nanoparticles for Small Molecule Targets and Antibodies in the ELISA Format,” Scientific Reports 6, no. 1 (2016): 37638. PubMed PMC

Canfarotta F., Cecchini A., and Piletsky S., “Nano‐Sized Molecularly Imprinted Polymers as Artificial Antibodies.” Mechanochemistry in Materials (Royal Society of Chemistry, 2018), 1–27.

Kassem S., Piletsky S. S., Yesilkaya H., et al., “Assessing the In Vivo Biocompatibility of Molecularly Imprinted Polymer Nanoparticles,” Polymers 14, no. 21 (2022): 4582. PubMed PMC

Rask‐Andersen M., Almén M. S., and Schiöth H. B., “Trends in the Exploitation of Novel Drug Targets,” Nature Reviews Drug Discovery 10, no. 8 (2011): 579–590. PubMed

Bleicher K. H., Böhm H.‐J., Müller K., and Alanine A. I., “Hit and Lead Generation: Beyond High‐Throughput Screening,” Nature Reviews Drug Discovery 2, no. 5 (2003): 369–378. PubMed

Copeland R., “Why Enzymes as Drug Targets.” Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists, 2nd ed (John Wiley & Sons, Inc, 2013), 1–23. PubMed

Copeland R. A., Harpel M. R., and Tummino P. J., “Targeting Enzyme Inhibitors in Drug Discovery,” Expert Opinion on Therapeutic Targets 11, no. 7 (2007): 967–978. PubMed

Cutivet A., Schembri C., Kovensky J., and Haupt K., “Molecularly Imprinted Microgels as Enzyme Inhibitors,” Journal of the American Chemical Society 131, no. 41 (2009): 14699–14702. PubMed

Zhang H., Jiang J., Zhang H., Zhang Y., and Sun P., “Efficient Synthesis of Molecularly Imprinted Polymers With Enzyme Inhibition Potency by the Controlled Surface Imprinting Approach,” ACS Macro Letters 2, no. 6 (2013): 566–570. PubMed

Zhang Z., Wang Z., Wang F., Ren J., and Qu X., “Programmable Downregulation of Enzyme Activity Using a Fever and NIR‐Responsive Molecularly Imprinted Nanocomposite,” Small 11, no. 46 (2015): 6172–6178. PubMed

Liu Y., Wang S., Zhang C., Su X., Huang S., and Zhao M., “Enhancing the Selectivity of Enzyme Detection by Using Tailor‐Made Nanoparticles,” Analytical Chemistry 85, no. 10 (2013): 4853–4857. PubMed

Zhai J., Zhao M., Cao X., Li M., and Zhao M., “Metal‐Ion‐Responsive Bionanocomposite for Selective and Reversible Enzyme Inhibition,” Journal of the American Chemical Society 140, no. 49 (2018): 16925–16928. PubMed

Liu Y., Fang S., Zhai J., and Zhao M., “Construction of Antibody‐Like Nanoparticles for Selective Protein Sequestration in Living Cells,” Nanoscale 7, no. 16 (2015): 7162–7167. PubMed

Chen J., Lei S., Zeng K., Wang M., Asif A., and Ge X., “Catalase‐Imprinted Fe3O4/Fe@ Fibrous SiO2/polydopamine Nanoparticles: An Integrated Nanoplatform of Magnetic Targeting, Magnetic Resonance Imaging, and Dual‐Mode Cancer Therapy,” Nano Research 10, no. 7 (2017): 2351–2363.

Zhang T., Dar K. K., Li Y., et al., “Abiotic Mimic of Matrix Metalloproteinase‐9 Inhibitor Against Advanced Metastatic Cancer,” ACS Biomaterials Science & Engineering 7, no. 7 (2021): 3190–3200. PubMed

Xu J., Miao H., Zou L., Tse Sum Bui B., Haupt K., and Pan G., “Evolution of Molecularly Imprinted Enzyme Inhibitors: From Simple Activity Inhibition to Pathological Cell Regulation,” Angewandte Chemie 133 (2021): 24731–24738. PubMed

Li X., Palhano Zanela T. M., Underbakke E. S., and Zhao Y., “Controlling Kinase Activities by Selective Inhibition of Peptide Substrates,” Journal of the American Chemical Society 143, no. 2 (2021): 639–643. PubMed

Piletsky S. A., Bedwell T. S., Paoletti R., et al., “Modulation of Acetylcholinesterase Activity Using Molecularly Imprinted Polymer Nanoparticles,” Journal of Materials Chemistry B 10 (2022): 6732–6741. PubMed

Canfarotta F., Poma A., Guerreiro A., and Piletsky S., “Solid‐Phase Synthesis of Molecularly Imprinted Nanoparticles,” Nature Protocols 11, no. 3 (2016): 443–455. PubMed

Cecchini A., Raffa V., Canfarotta F., et al., “In Vivo Recognition of Human Vascular Endothelial Growth Factor by Molecularly Imprinted Polymers,” Nano Letters 17, no. 4 (2017): 2307–2312. PubMed

Koide H., Yoshimatsu K., Hoshino Y., et al., “A Polymer Nanoparticle With Engineered Affinity for a Vascular Endothelial Growth Factor (VEGF 165),” Nature Chemistry 9, no. 7 (2017): 715–722. PubMed

Niu G. and Chen X., “Vascular Endothelial Growth Factor as An Anti‐Angiogenic Target for Cancer Therapy,” Current Drug Targets 11, no. 8 (2010): 1000–1017. PubMed PMC

Koide H., Yoshimatsu K., Hoshino Y., et al., “Sequestering and Inhibiting a Vascular Endothelial Growth Factor In Vivo by Systemic Administration of a Synthetic Polymer Nanoparticle,” Journal of Controlled Release 295 (2019): 13–20. PubMed

Tang X., Li F., Jia J., et al., “Synthesis of Magnetic Molecularly Imprinted Polymers With Excellent Biocompatibility for the Selective Separation and Inhibition of Testosterone in Prostate Cancer Cells,” International Journal of Nanomedicine 12 (2017): 2979–2993. PubMed PMC

Zitzmann M. and Nieschlag E., “Testosterone Levels in Healthy Men and the Relation to Behavioural and Physical Characteristics: Facts and Constructs,” European Journal of Endocrinology 144, no. 3 (2001): 183–197. PubMed

Zhou Z.‐R., Wang X.‐Y., Jiang L., Li D.‐W., and Qian R.‐C., “Sialidase‐Conjugated “Nanoniche” for Efficient Immune Checkpoint Blockade Therapy,” ACS Applied Bio Materials 4, no. 7 (2021): 5735–5741. PubMed

Alard E., Butnariu A.‐B., Grillo M., et al., “Advances in Anti‐Cancer Immunotherapy: Car‐T Cell, Checkpoint Inhibitors, Dendritic Cell Vaccines, and Oncolytic Viruses, and Emerging Cellular and Molecular Targets,” Cancers 12, no. 7 (2020): 1826. PubMed PMC

Kaszak I., Witkowska‐Piłaszewicz O., Niewiadomska Z., Dworecka‐Kaszak B., Ngosa Toka F., and Jurka P., “Role of Cadherins in Cancer—A Review,” International Journal of Molecular Sciences 21, no. 20 (2020): 7624. PubMed PMC

Medina Rangel P. X., Moroni E., Merlier F., et al., “Chemical Antibody Mimics Inhibit Cadherin‐Mediated Cell–Cell Adhesion: A Promising Strategy for Cancer Therapy,” Angewandte Chemie International Edition 59, no. 7 (2020): 2816–2822. PubMed

Rangel P. X. M., Mier A., Moroni E., et al., “Molecularly Imprinted Polymer Nanogels Targeting the HAV Motif in Cadherins Inhibit Cell–Cell Adhesion and Migration,” Journal of Materials Chemistry B 10 (2022): 6688–6697. PubMed

Iqbal N. and Iqbal N., “Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications,” Molecular Biology International 2014 (2014): 1–9. PubMed PMC

Dong Y., Li W., Gu Z., et al., “Inhibition of HER2‐positive Breast Cancer Growth by Blocking the HER2 Signaling Pathway With HER2‐Glycan‐imprinted Nanoparticles,” Angewandte Chemie International Edition 58, no. 31 (2019): 10621–10625. PubMed

Santos R., Ursu O., Gaulton A., et al., “A Comprehensive Map of Molecular Drug Targets,” Nature Reviews Drug Discovery 16, no. 1 (2017): 19–34. PubMed PMC

Banerjee N. and Mukhopadhyay S., “Viral Glycoproteins: Biological Role and Application in Diagnosis,” VirusDisease 27, no. 1 (2016): 1–11. PubMed PMC

Chou C.‐Y., Lin C.‐Y., Wu C.‐H., and Tai D.‐F., “Sensing HIV Protease and Its Inhibitor Using ʻHelical Epitopeʼ—Imprinted Polymers,” Sensors 20, no. 12 (2020): 3592. PubMed PMC

Sankarakumar N. and Tong Y. W., “Preventing Viral Infections With Polymeric Virus Catchers: A Novel Nanotechnological Approach to Anti‐Viral Therapy,” Journal of Materials Chemistry B 1, no. 15 (2013): 2031–2037. PubMed

Li N., Liu Y., Liu F., et al., “Bio‐Inspired Virus Imprinted Polymer for Prevention of Viral Infections,” Acta Biomaterialia 51 (2017): 175–183. PubMed

Graham S. P., El‐Sharif H. F., Hussain S., et al., “Evaluation of Molecularly Imprinted Polymers as Synthetic Virus Neutralizing Antibody Mimics,” Frontiers in Bioengineering and Biotechnology 7 (2019): 115. PubMed PMC

Xu J., Merlier F., Avalle B., et al., “Molecularly Imprinted Polymer Nanoparticles as Potential Synthetic Antibodies for Immunoprotection Against HIV,” ACS Applied Materials & Interfaces 11, no. 10 (2019): 9824–9831. PubMed

Parisi O. I., Dattilo M., Patitucci F., et al., “Design and Development of Plastic Antibodies Against SARS‐CoV‐2 RBD Based on Molecularly Imprinted Polymers That Inhibit In Vitro Virus Infection,” Nanoscale 13, no. 40 (2021): 16885–16899. PubMed

Parisi O. I., Dattilo M., Patitucci F., et al., “Design and Development of Plastic Antibodies Against SARS‐CoV‐2 RBD Based on Molecularly Imprinted Polymers That Inhibit In Vitro Virus Infection,” Nanoscale 13, no. 40 (2021): 16885–16899, 10.1039/d1nr03727g. PubMed DOI

Zambelli V., Picolo G., Fernandes C., Fontes M., and Cury Y., “Secreted Phospholipases A2 From Animal Venoms in Pain and Analgesia,” Toxins 9, no. 12 (2017): 406. PubMed PMC

Klint J. K., Senff S., Saez N. J., et al., “Production of Recombinant Disulfide‐Rich Venom Peptides for Structural and Functional Analysis via Expression in the Periplasm of PubMed PMC

Waheed H., Moin S. F., and Choudhary M. I., “Snake Venom: From Deadly Toxins to Life‐Saving Therapeutics,” Current Medicinal Chemistry 24, no. 17 (2017): 1874–1891. PubMed

Hoshino Y., Koide H., Urakami T., et al., “Recognition, Neutralization, and Clearance of Target Peptides in the Bloodstream of Living Mice by Molecularly Imprinted Polymer Nanoparticles: A Plastic Antibody,” Journal of the American Chemical Society 132, no. 19 (2010): 6644–6645. PubMed PMC

Hoshino Y., Koide H., Furuya K., et al., “The Rational Design of a Synthetic Polymer Nanoparticle That Neutralizes a Toxic Peptide In Vivo,” Proceedings of the National Academy of Sciences 109, no. 1 (2012): 33–38. PubMed PMC

Piszkiewicz S., Kirkbride E. A., Doreng‐Stearns N., et al., “Molecularly‐Imprinted Nanoparticles That Recognize PubMed